ACRS
Aclaris TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ACRS vs peer average
55/100
ACRS vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
REGN is the first available peer comparator.
A much larger immunology benchmark rather than a true valuation peer, but useful for framing how investors reward differentiated dermatology and inflammation assets once data quality improves.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACRS
Aclaris Therapeutics
REGN
Regeneron
Grade
C
B
Momentum
7
81
Value
41
63
Sentiment
77
49
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs REGN
ACRS / REGN
Grade Position
In line
ACRS vs. peer average (C vs. C)
55/100
Momentum
7
REGNValue
41
REGNSentiment
77
ACRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACRS
REGN is the first peer returned for this comparison set.